Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Hugo A Barrera-Saldaña"'
Autor:
Ana Laura Calderón-Garcidueñas, Pablo Ruiz-Flores, Ricardo M Cerda-Flores, Hugo A Barrera-Saldaña
Publikováno v:
Salud Pública de México, Vol 47, Iss 2, Pp 110-115 (2005)
OBJECTIVE: This study describes the presence of mutations in BRCA1 and BRCA2 genes in a group of Mexican women and the clinical evolution of early onset breast cancer (EOBC). MATERIAL AND METHODS: A prospective hospital-based study was performed in a
Externí odkaz:
https://doaj.org/article/2c8eaea63fb54a5ebd6f11756ba4c400
Autor:
Celia N Sanchez-Dominguez, Miguel A Reyes-Lopez, Adriana Bustamante, Ricardo M Cerda-Flores, Maria Del C Villalobos-Torres, Hugo L Gallardo-Blanco, Augusto Rojas-Martinez, Herminia G Martinez-Rodriguez, Hugo A Barrera-Saldaña, Rocio Ortiz-Lopez
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90945 (2014)
UnlabelledEnvironmental and genetic factors may modify or contribute to the phenotypic differences observed in multigenic and monogenic diseases, such as cystic fibrosis (CF). An analysis of modifier genes can be helpful for estimating patient progno
Externí odkaz:
https://doaj.org/article/b271aec9d93a4daca8f8f59b74fbe472
Autor:
José L. Castrillo-Diez, Carolina Rivera-Santiago, Silvia M. Ávila-Flores, Silvia A. Barrera-Barrera, Hugo A. Barrera-Saldaña
Publikováno v:
Viruses, Vol 16, Iss 6, p 887 (2024)
We have been encouraging practicing gynecologists to adopt molecular diagnostics tests, PCR, and cancer biomarkers, as alternatives enabled by these platforms, to traditional Papanicolaou and colposcopy tests, respectively. An aliquot of liquid-based
Externí odkaz:
https://doaj.org/article/9e5c74a3c51142cea487f7b15ef500fe
Publikováno v:
Pharmaceuticals, Vol 16, Iss 9, p 1334 (2023)
Cellular therapy has used mesenchymal stem cells (MSCs), which in cell culture are multipotent progenitors capable of producing a variety of cells limited to the mesoderm layer. There are two types of MSC sources: (1) adult MSCs, which are obtained f
Externí odkaz:
https://doaj.org/article/49b32a2c09994ef38df5d0bcaa920fe0
Autor:
Andrei Rajkovic, Sandesh Kanchugal, Eldar Abdurakhmanov, Rebecca Howard, Sebastian Wärmländer, Joseph Erwin, Hugo A Barrera Saldaña, Astrid Gräslund, Helena Danielson, Samuel Coulbourn Flores
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282741 (2023)
The interaction between human Growth Hormone (hGH) and hGH Receptor (hGHR) has basic relevance to cancer and growth disorders, and hGH is the scaffold for Pegvisomant, an anti-acromegaly therapeutic. For the latter reason, hGH has been extensively en
Externí odkaz:
https://doaj.org/article/eab598788a8244cb8440ab700095f932
Autor:
Hugo A. Barrera-Saldaña
Publikováno v:
Gaceta Médica de México, Vol 158, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/85a598fadb234293b263eb41e9e2fac3
Autor:
María Lourdes Garza-Rodríguez, Antonio Alí Pérez-Maya, Daniela Estefanía Monsivais-Ovalle, Juan Francisco Velázquez-Vadillo, Hugo Alberto Barrera-Saldaña
Publikováno v:
Salud Pública de México, Vol 58, Iss 4, Pp 483-489 (2016)
Los biobancos constituyen puentes efectivos entre grupos de investigación básicos y clínicos para generar conocimientos y aplicaciones que eleven su competitividad internacional. Se revisaron las tareas realizadas y los logros alcanzados durante l
Externí odkaz:
https://doaj.org/article/205b68e95a1c49769e7ef633a3e37dbc
Autor:
Priscilla Denise Zepeda-Lopez, Julio Cesar Salas-Alanis, Sonia Toussaint-Caire, Daniela Gutierrez-Mendoza, Elisa Vega-Memije, Saúl Lino Silva, Oscar Raul Fajardo-Ramírez, Gregorio Alcazar, María Guadalupe Moreno-Treviño, Hugo Alberto Barrera Saldaña
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 1, Pp 241-245 (2016)
Background: B-Raf is a serine/threonine protein kinase activating the MAP kinase/ERK-signaling pathway. It has been shown that 50% of melanomas harbor activating BRAF mutations, with over 90% being the V600E mutation. Objective: The goal of this rese
Externí odkaz:
https://doaj.org/article/760ab20b304344f0ac64d01142ad6440
Publikováno v:
Microbiology spectrum.
Coronavirus disease 2019 (COVID-19) was first detected in Mexico in February 2020. Even though health authorities did not perceive then the value of viral detection tests, we anticipated the demand for them. We set up to develop an expeditious severe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af29cf8ebde7edbb59bca4a3ffb4ecfd
https://pubmed.ncbi.nlm.nih.gov/36314981
https://pubmed.ncbi.nlm.nih.gov/36314981
Autor:
Hugo A. Barrera-Saldaña
Publikováno v:
Revista Medicina Universitaria. 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6843ae81a7e82f14d9e024156bf8618f
https://doi.org/10.24875/rmu.m22000068
https://doi.org/10.24875/rmu.m22000068